focus -WSS

focus

author：explore 2025-10-01 12:33:53 - browse：89

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Princess Kate attends Wimbledon with Roger Federer: See the photos

hotspot

WSS

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Inside the rise of 'mukbang' eating videos

Altering the blood type of lungs raises potential for universal organs for transplants

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Search warrant issued in 1996 disappearance of Kristin Smart

Biden administration plans revamp of organ transplant system

hotspot

focus

focus

Duchenne breakthrough therapy leaves behind pioneering families

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Novavax promises a turnaround & Lilly roils the obesity market

Biogen nominates mother of director’s child to replace him on board

Medicare details structure of new drug price negotiation program

Biden administration plans revamp of organ transplant system

State Dept. review finds Biden bears some blame for Afghanistan failures

Inside the rise of 'mukbang' eating videos

Medical records are filled with copy

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Wikipedia

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Inside the rise of 'mukbang' eating videos

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Pentagon will tighten controls on classified information after Discord leak

A bus careens into a gulch in southern Mexico, leaving 27 people dead

knowledge

hotspot

explore

hotspot